Rallybio CorporationRLYBNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-60.37M
↓ 23% below average
Average (5y)
$-49.15M
Historical baseline
Range
High:$-17.39M
Low:$-78.78M
CAGR
+28.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-60.37M | +23.4% |
| 2023 | $-78.78M | -16.3% |
| 2022 | $-67.72M | -49.2% |
| 2021 | $-45.39M | -79.8% |
| 2020 | $-25.24M | -45.1% |
| 2019 | $-17.39M | - |